![](/img/cover-not-exists.png)
Re-evaluate the Efficacy and Safety of Human Urinary Kallidinogenase (RESK): Protocol for an Open-Label, Single-Arm, Multicenter Phase IV Trial for the Treatment of Acute Ischemic Stroke in Chinese Patients
Ni, Jun, Qu, Jiazhi, Yao, Ming, Zhang, Zhijun, Zhong, Xihua, Cui, LiyingVolume:
8
Language:
english
Journal:
Translational Stroke Research
DOI:
10.1007/s12975-017-0527-5
Date:
August, 2017
File:
PDF, 427 KB
english, 2017